STOCK TITAN

Sartorius Expands Bio-Circular Product Offering for More Sustainable Bioprocesses

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Sartorius (OTC: SUVPF) expanded its ISCC Plus certified production network on January 14, 2026, adding Göttingen, Germany and M'Hamdia, Tunisia to earlier-certified sites in Aubagne, France and Stonehouse, UK.

The company will produce the PFAS-free Sartopore Evo filter in Göttingen and selected Flexsafe bags in M'Hamdia using certified renewable or second-generation feedstock, lowering fossil-based content by about 70% in Flexsafe film and 40–60% in Sartopore Evo filters. Sartorius said it plans to expand certified raw-material use across its global production network.

Loading...
Loading translation...

Positive

  • ISCC Plus certification added at Göttingen and M'Hamdia
  • Flexsafe fossil-based compounds reduced ~70%
  • Sartopore Evo fossil-based compounds reduced 40–60%
  • Production includes PFAS-free Sartopore Evo at Göttingen

Negative

  • None.
  • Further production hubs in Germany and Tunisia now certified by International Sustainability and Carbon Certification

  • Certified raw materials significantly reduce dependence on fossil-based plastics

  • Bio-circular filters and additional single-use fluid management technologies now available for biopharma manufacturers

  • Certified production network spans sites in Germany, Tunisia, France and the UK

GÖTTINGEN, DE / ACCESS Newswire / January 14, 2026 / Sartorius is expanding its bio-based product portfolio to support the biopharma industry's push toward more sustainable manufacturing. With ISCC Plus certification now extended to its sites in Göttingen, Germany, and M'Hamdia, Tunisia, the company can use certified renewable raw materials in additional product lines, reducing the share of fossil-based plastics while ensuring full compatibility with existing bioprocesses.

ISCC Plus is a global standard for renewable and recycled raw materials that ensures transparent and traceable sourcing and compliance across the value chain based on a mass-balance system. At its Göttingen headquarters, Sartorius will produce the PFAS-free filter Sartopore Evo using ISCC Plus-certified materials. In M'Hamdia, selected Flexsafe bags will be manufactured with certified second generation feedstock. The use of ISCC Plus-certified materials enables a reduction of fossil-based compounds by around 70 percent in the Flexsafe film and by an average 40-60 percent in Sartopore Evo filters.

"Our biopharma customers aim to increase production output while delivering on ambitious sustainability goals. Sartorius' single-use technologies and process intensification solutions have long helped biopharma manufacturers make their processes more efficient - increasing output and reducing environmental impact," said René Fáber, Head of the Bioprocess Division and Member of the Executive Board at Sartorius. "By integrating ISCC Plus-certified materials into additional key product groups, we are offering more sustainable alternatives while ensuring full compatibility with existing workflows. This reflects our commitment to reducing fossil-based materials and advancing sustainability in biomanufacturing."

Earlier in 2025, Sartorius achieved ISCC Plus certification for its sites in Aubagne, France, and Stonehouse, United Kingdom, covering its Ambr bioreactor vessels, Vivaflow filters, and selected Flexsafe bags for the manufacture of biopharmaceutical. The company plans to expand the use of certified renewable raw materials across its global production network.

A profile of Sartorius
Sartorius is a leading international partner to the biopharmaceutical research and manufacturing industries. The Lab Products & Services Division focuses on innovative laboratory instruments and consumables for research and quality assurance laboratories in pharmaceutical and biopharmaceutical companies as well as academic research institutions. The Bioprocess Solutions Division supports customers with a broad product portfolio focused on single-use solutions for the safer, faster, and more sustainable production of biotech drugs, vaccines, and cell and gene therapies. With around 60 production and sales locations worldwide, the Göttingen-based company has a strong global presence. Sartorius regularly supplements its portfolio with acquisitions of complementary technologies. In 2024, the company generated sales revenue of around 3.4 billion euros. More than 13,500 employees serve customers around the globe.

Visit our newsroom and follow us on LinkedIn.

Contact
Leona Malorny
Head of External Communications
+49 551 308 4067
leona.malorny@sartorius.com

SOURCE: SARTORIUS AG



View the original press release on ACCESS Newswire

FAQ

What did Sartorius announce on January 14, 2026 about ISCC Plus certification for SUVPF?

Sartorius said it extended ISCC Plus certification to Göttingen and M'Hamdia, adding to sites in France and the UK.

How much will SUVPF's Flexsafe film reduce fossil-based content after the change?

Sartorius reported an approximate 70% reduction in fossil-based compounds for Flexsafe film using certified materials.

What fossil-reduction range did Sartorius report for Sartopore Evo filters (SUVPF)?

The company reported an average reduction of 40–60% in fossil-based materials for Sartopore Evo filters.

Which products will be produced with certified materials at the new SUVPF-certified sites?

Göttingen will produce the PFAS-free Sartopore Evo filter and M'Hamdia will manufacture selected Flexsafe bags with certified feedstock.

Does the SUVPF announcement affect existing workflows for biopharma manufacturers?

Sartorius stated the certified products are fully compatible with existing bioprocess workflows.

How does the SUVPF certification fit into Sartorius' global production footprint and 2024 sales context?

The company said certifications cover sites across Germany, Tunisia, France and the UK and noted ~3.4 billion euros in 2024 sales as context for its global operations.
Sartorius Ag Pfd

OTC:SUVPF

SUVPF Rankings

SUVPF Latest News

SUVPF Stock Data

14.69B
25.22M
25.61%
27.78%
Medical Instruments & Supplies
Healthcare
Link
Germany
Göttingen